Further, in rats with DMBA-induced mammary gland tumors, pretreatment with hesperetin (50 mg/kg BW/day) significantly reduced the tumor burden and the overexpression of the proliferating cell nuclear antigen (PCNA), as well as restoring the decreased Bcl-2 and increased Bax expression. The gene discussed is PCNA; the disease is neoplasm.